Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Food intake does not alter the pharmacokinetics of multiple-dose lonafarnib

April 7, 2003

PTK-787/ZK-222584 enters phase III for metastatic colorectal cancer

April 4, 2003

New synthetic gangliosides with utility in glioma and neurological disorders

April 4, 2003

Phase II repifermin trial demonstrates efficacy in cancer therapy-induced mucositis

April 4, 2003

Patrin enters phase II trial in metastatic melanoma

April 4, 2003

Wyeth exercises option for Oxford BioMedica's anticancer antibody

April 4, 2003

Characterization of new CDK1/CDK2 inhibitor

April 3, 2003

Ganite sNDA filing completed

April 3, 2003

Oral zebularine reactivates silenced genes, inhibits DNA methylation

April 3, 2003

Yissum researchers prepare and test new DNA-damaging platinum complexes

April 3, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...